These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 22340435)

  • 1. Societal and individual burden of illness among fibromyalgia patients in France: association between disease severity and OMERACT core domains.
    Perrot S; Schaefer C; Knight T; Hufstader M; Chandran AB; Zlateva G
    BMC Musculoskelet Disord; 2012 Feb; 13():22. PubMed ID: 22340435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The comparative economic burden of mild, moderate, and severe fibromyalgia: results from a retrospective chart review and cross-sectional survey of working-age U.S. adults.
    Chandran A; Schaefer C; Ryan K; Baik R; McNett M; Zlateva G
    J Manag Care Pharm; 2012; 18(6):415-26. PubMed ID: 22839682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of patients with fibromyalgia in France and Germany.
    Perrot S; Winkelmann A; Dukes E; Xu X; Schaefer C; Ryan K; Chandran A; Sadosky A; Zlateva G
    Int J Clin Pract; 2010 Jul; 64(8):1100-8. PubMed ID: 20497264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comparative burden of mild, moderate and severe fibromyalgia: results from a cross-sectional survey in the United States.
    Schaefer C; Chandran A; Hufstader M; Baik R; McNett M; Goldenberg D; Gerwin R; Zlateva G
    Health Qual Life Outcomes; 2011 Aug; 9():71. PubMed ID: 21859448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward characterization and definition of fibromyalgia severity.
    Silverman S; Sadosky A; Evans C; Yeh Y; Alvir JM; Zlateva G
    BMC Musculoskelet Disord; 2010 Apr; 11():66. PubMed ID: 20377879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burden of illness in fibromyalgia patients with comorbid depression.
    Bateman L; Sarzi-Puttini P; Burbridge CL; Landen JW; Masters ET; Bhadra Brown P; Scavone JM; Emir B; Vissing RS; Clair AG; Pauer LR
    Clin Exp Rheumatol; 2016; 34(2 Suppl 96):S106-13. PubMed ID: 27057659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Comparative Burden of Chronic Widespread Pain and Fibromyalgia in the United States.
    Schaefer C; Mann R; Masters ET; Cappelleri JC; Daniel SR; Zlateva G; McElroy HJ; Chandran AB; Adams EH; Assaf AR; McNett M; Mease P; Silverman S; Staud R
    Pain Pract; 2016 Jun; 16(5):565-79. PubMed ID: 25980433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost of illness and illness perceptions in patients with fibromyalgia.
    Vervoort VM; Vriezekolk JE; Olde Hartman TC; Cats HA; van Helmond T; van der Laan WH; Geenen R; van den Ende CH
    Clin Exp Rheumatol; 2016; 34(2 Suppl 96):S74-82. PubMed ID: 26886404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of fibromyalgia severity on health economic costs: results from a European cross-sectional study.
    Winkelmann A; Perrot S; Schaefer C; Ryan K; Chandran A; Sadosky A; Zlateva G
    Appl Health Econ Health Policy; 2011 Mar; 9(2):125-36. PubMed ID: 21332254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resource utilisation and health care costs in patients diagnosed with fibromyalgia in Spain.
    Rivera J; Rejas J; Esteve-Vives J; Vallejo MA;
    Clin Exp Rheumatol; 2009; 27(5 Suppl 56):S39-45. PubMed ID: 20074438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibromyalgia Impact Reduction Using Online Personal Health Informatics: Longitudinal Observational Study.
    Collinge W; Soltysik R; Yarnold P
    J Med Internet Res; 2020 Apr; 22(4):e15819. PubMed ID: 32131045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of fibromyalgia on health status according to the types, demographic background and pain index.
    Ghavidel-Parsa B; Bidari A; Maafi AA; Hassankhani A; Hajiabbasi A; Montazeri A; Sanaei O; Ghalehbaghi B
    Clin Exp Rheumatol; 2016; 34(2 Suppl 96):S134-9. PubMed ID: 27157398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High cost of illness in fibromyalgia patients in Iran, irrespective of disease severity: A prospective cost study.
    Gharibpoor F; Nasrollahzadeh E; Ghavidel-Parsa B; Ghaffari ME; Bidari A
    Int J Rheum Dis; 2021 May; 24(5):671-680. PubMed ID: 33729682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study of the use of healthcare resources and economic costs in patients with fibromyalgia after treatment in routine medical practice.
    Rivera J; Rejas-Gutiérrez J; Vallejo MA; Esteve-Vives J; De Salas-Cansado M;
    Clin Exp Rheumatol; 2012; 30(6 Suppl 74):31-8. PubMed ID: 22935246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychometric properties of the Fibromyalgia Assessment Status (FAS) index: a national web-based study of fibromyalgia.
    Iannuccelli C; Sarzi-Puttini P; Atzeni F; Cazzola M; di Franco M; Guzzo MP; Bazzichi L; Cassisi GA; Marsico A; Stisi S; Salaffi F
    Clin Exp Rheumatol; 2011; 29(6 Suppl 69):S49-54. PubMed ID: 22011656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal clinically important difference in the fibromyalgia impact questionnaire.
    Bennett RM; Bushmakin AG; Cappelleri JC; Zlateva G; Sadosky AB
    J Rheumatol; 2009 Jun; 36(6):1304-11. PubMed ID: 19369473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 2010 American college of rheumatology fibromyalgia survey diagnostic criteria and symptom severity scale is a valid and reliable tool in a French speaking fibromyalgia cohort.
    Fitzcharles MA; Ste-Marie PA; Panopalis P; Ménard H; Shir Y; Wolfe F
    BMC Musculoskelet Disord; 2012 Sep; 13():179. PubMed ID: 22994975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OMERACT-based fibromyalgia symptom subgroups: an exploratory cluster analysis.
    Vincent A; Hoskin TL; Whipple MO; Clauw DJ; Barton DL; Benzo RP; Williams DA
    Arthritis Res Ther; 2014 Oct; 16(5):463. PubMed ID: 25318839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the economic benefits of positive shifts in fibromyalgia severity: an exploratory analysis based on modeling of clinical trial data of pregabalin.
    Cappelleri JC; Bushmakin AG; Zlateva G; Chandran A
    J Med Econ; 2013; 16(1):55-61. PubMed ID: 22954060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do we need core sets of fibromyalgia domains? The assessment of fibromyalgia (and other rheumatic disorders) in clinical practice.
    Wolfe F; Hassett AL; Katz RS; Michaud K; Walitt B
    J Rheumatol; 2011 Jun; 38(6):1104-12. PubMed ID: 21285168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.